FIELD: technological processes; pharmacology.
SUBSTANCE: method is implemented in the following manner: pH of initial solution is brought to 4.6-4.95, and caprilat- and/or heptanoate-ions are added to it, while pH is maintained at the level of 4.8-4.95. Supernatant solution is incubated under conditions, at which concentration of caprilat- and/or heptanoate-ions makes 10-30 mM. Filtered solution is applied on anion-exchanging resin, under conditions that provide binding of contaminating admixtures with resin in the absence of considerable binding of antibodies with resin.
EFFECT: method makes it possible to produce preparation of antibody that is purified, virologically safe and inactivated from virological point of view.
22 cl, 2 dwg, 2 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARING GAMMA-GLOBULIN SOLUTION DESIGNATED FOR INTRAVENOUS ADMINISTRATION AND PREPARATION PREPARING BY THIS METHOD | 1998 |
|
RU2198668C2 |
| METHOD OF ALPHA-1-ANTITRYPSIN SOLUTION TREATMENT | 2004 |
|
RU2370500C2 |
| PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING | 2007 |
|
RU2520817C2 |
| METHOD OF PRODUCING FIBRINOGEN USING STRONG ANION EXCHANGE RESIN AND FIBRINOGEN-CONTAINING PRODUCT | 2011 |
|
RU2603103C2 |
| METHOD OF PREPARING IMMUNOGLOBULINS FOR INTRAVENOUS ADMINISTRATION AND OTHER IMMUNOGLOBULIN PREPARATIONS | 1999 |
|
RU2197500C2 |
| METHOD OF PRODUCING IMMUNOGLOBULINS | 2016 |
|
RU2708394C2 |
| METHOD OF PRODUCING HUMAN IMMUNOGLOBULIN | 2013 |
|
RU2614119C9 |
| METHOD OF PRODUCING IGG COMPOSITION BY THERMAL PROCESSING | 2013 |
|
RU2636049C2 |
| METHOD OF PURIFYING THERAPEUTIC PROTEINS | 2013 |
|
RU2685956C2 |
| PRODUCTION OF IMMUNOGLOBULINS WITH REDUCED THROMBOGENIC AGENT CONTENT, AND IMMUNOGLOBULIN COMPOSITION | 2012 |
|
RU2627162C2 |
